From the Research
The RGCC protocol is not a standardized or evidence-based cancer treatment protocol, and its use is not recommended due to the lack of peer-reviewed scientific evidence supporting its reliability or clinical utility. The RGCC test is a controversial blood test that claims to detect circulating tumor cells and provide personalized cancer treatment recommendations, but it is not approved by major regulatory bodies like the FDA or endorsed by mainstream oncology organizations 1. Conventional cancer treatments, including surgery, radiation, chemotherapy, immunotherapy, and targeted therapies, remain the evidence-based standard of care for cancer patients, and have undergone rigorous clinical trials demonstrating their efficacy and safety profiles 2.
Some studies have discussed the potential of targeted therapies in cancer treatment, including the use of monoclonal antibodies and small molecule inhibitors, but these treatments are typically used in combination with other established therapies and are guided by FDA-approved genomic testing options 2. Other studies have highlighted the importance of considering the impact of chemotherapy, radiation therapy, and molecularly targeted therapy on the host anti-tumor immune response and the host anti-host response when designing immunotherapy-based combination regimens 3.
In terms of radiation therapy, it remains an important component of cancer treatment, with approximately 50% of all cancer patients receiving radiation therapy during their course of illness, and contributes towards 40% of curative treatment for cancer 4. However, the use of radiation therapy is guided by established protocols and evidence-based guidelines, rather than controversial or unproven tests like the RGCC protocol.
Overall, patients interested in personalized cancer treatment approaches should discuss FDA-approved genomic testing options with their oncologists, which can identify specific genetic mutations in tumors that may respond to targeted therapies with proven clinical benefits, rather than relying on unproven or controversial tests like the RGCC protocol. The most effective approach to cancer treatment is a multidisciplinary one, incorporating established therapies and guided by evidence-based guidelines and FDA-approved testing options.